Cargando…
Dose and time responses of vitamin D biomarkers to monthly vitamin D(3) supplementation in overweight/obese African Americans with suboptimal vitamin d status: a placebo controlled randomized clinical trial
BACKGROUND: A critical need exists to better understand the physiological sequel of vitamin D supplementation in obese individuals and African Americans. The aim was to comprehensively evaluate dose- and time-responses of a panel of vitamin D biomarkers to vitamin D supplements in this population. M...
Autores principales: | Bhagatwala, Jigar, Zhu, Haidong, Parikh, Samip J., Guo, De-Huang, Kotak, Ishita, Huang, Ying, Havens, Robyn, Pham, Michael, Afari, Eric, Kim, Susan, Cutler, Christopher, Pollock, Norman K., Dong, Yutong, Raed, Anas, Dong, Yanbin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4511449/ https://www.ncbi.nlm.nih.gov/pubmed/26217542 http://dx.doi.org/10.1186/s40608-015-0056-2 |
Ejemplares similares
-
Dose responses of vitamin D(3) supplementation on arterial stiffness in overweight African Americans with vitamin D deficiency: A placebo controlled randomized trial
por: Raed, Anas, et al.
Publicado: (2017) -
Race/Ethnicity-Specific Association of Vitamin D and Global DNA Methylation: Cross-Sectional and Interventional Findings
por: Zhu, Haidong, et al.
Publicado: (2016) -
Correction: Race/Ethnicity-Specific Association of Vitamin D and Global DNA Methylation: Cross-Sectional and Interventional Findings
por: Zhu, Haidong, et al.
Publicado: (2016) -
Vitamin D(3) Supplementation Increases Long-Chain Ceramide Levels in Overweight/Obese African Americans: A Post-Hoc Analysis of a Randomized Controlled Trial
por: Chen, Li, et al.
Publicado: (2020) -
Sixteen-Week Vitamin D(3) Supplementation Increases Peripheral T Cells in Overweight Black Individuals: Post hoc Analysis of a Randomized, Double-Blinded, Placebo-Controlled Trial
por: Dong, Yutong, et al.
Publicado: (2022)